New

Vigabatrin Market

2021

Vigabatrin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Tablet, Powder); Application (Infantile Spasms (IS), Partial-Onset Seizures, Refractory Complex Partial Seizures) and Geography

| Report Code: TIPRE00025968 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Vigabatrin Market 2028 By Product, Application and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Vigabatrin is indicated as adjunctive treatment of Epilepsy, Infantile Spasms, and complex partial seizures. It is available as generic medicine in the global market. The growing demand for vigabatrin has increased the need for vigabatrin. Due to its prolonged activity in a short time is has a famous market.

MARKET SCOPE

The "Global Vigabatrin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Vigabatrin market with detailed market segmentation by product and application. The report provides key statistics on the market status of the leading vigabatrin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on product type the market is segmented as tablet and powder.
  •   Based on application the market is segmented as infantile spasms (IS), Partial-onset seizures and refractory complex partial seizures.
  •  

MARKET DYNAMICS
Drivers:

  •   Significant growth in use of antiepileptic agents.
  •   Increasing number of a epilepsy patients over the world.
  •   Increasing prevalnece of chronic epileptic diseases, infantile spasms

Restraints:

  •   Issues such as higher manufacturing cost affects the compitative market.
  •   Availability issues due to Covid 19 Pandemic over the world.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Vigabatrin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the vigabatrin market in these regions.

IMPACT OF COVID-19 ON VIGABATRIN MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. COVID-19 has disrupted all the business and economic activities across the globe which is expected to have some impact on vigabatrin market. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Vigabtrin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from vigabatrin market are anticipated to lucrative growth opportunities in the future with the rising demand for Vigabatrin in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Vigabatrin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   AVENTIS
  •   PAR PHARMACEUTICALS
  •   DR. REDDY'S LABORATORIES
  •   ACCORD HEALTHCARE
  •   NAVISCI
  •   CIPLA
  •   AMNEAL
  •   LUNDBECK
  •   CAMBER
  •   UPSHER-SMITH LABORATORIES
  •   DIVIS LABORATORIES
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vigabatrin Market - By Product
1.3.2 Vigabatrin Market - By Application
1.3.3 Vigabatrin Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. VIGABATRIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. VIGABATRIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. VIGABATRIN MARKET - GLOBAL MARKET ANALYSIS
6.1. VIGABATRIN - GLOBAL MARKET OVERVIEW
6.2. VIGABATRIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. VIGABATRIN MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. TABLET
7.3.1. Overview
7.3.2. Tablet Market Forecast and Analysis
7.4. POWDER
7.4.1. Overview
7.4.2. Powder Market Forecast and Analysis
8. VIGABATRIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. INFANTILE SPASMS (IS)
8.3.1. Overview
8.3.2. Infantile Spasms (IS) Market Forecast and Analysis
8.4. PARTIAL-ONSET SEIZURES
8.4.1. Overview
8.4.2. Partial-Onset Seizures Market Forecast and Analysis
8.5. REFRACTORY COMPLEX PARTIAL SEIZURES
8.5.1. Overview
8.5.2. Refractory Complex Partial Seizures Market Forecast and Analysis

9. VIGABATRIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Vigabatrin Market Overview
9.1.2 North America Vigabatrin Market Forecasts and Analysis
9.1.3 North America Vigabatrin Market Forecasts and Analysis - By Product
9.1.4 North America Vigabatrin Market Forecasts and Analysis - By Application
9.1.5 North America Vigabatrin Market Forecasts and Analysis - By Countries
9.1.5.1 United States Vigabatrin Market
9.1.5.1.1 United States Vigabatrin Market by Product
9.1.5.1.2 United States Vigabatrin Market by Application
9.1.5.2 Canada Vigabatrin Market
9.1.5.2.1 Canada Vigabatrin Market by Product
9.1.5.2.2 Canada Vigabatrin Market by Application
9.1.5.3 Mexico Vigabatrin Market
9.1.5.3.1 Mexico Vigabatrin Market by Product
9.1.5.3.2 Mexico Vigabatrin Market by Application
9.2. EUROPE
9.2.1 Europe Vigabatrin Market Overview
9.2.2 Europe Vigabatrin Market Forecasts and Analysis
9.2.3 Europe Vigabatrin Market Forecasts and Analysis - By Product
9.2.4 Europe Vigabatrin Market Forecasts and Analysis - By Application
9.2.5 Europe Vigabatrin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Vigabatrin Market
9.2.5.1.1 Germany Vigabatrin Market by Product
9.2.5.1.2 Germany Vigabatrin Market by Application
9.2.5.2 France Vigabatrin Market
9.2.5.2.1 France Vigabatrin Market by Product
9.2.5.2.2 France Vigabatrin Market by Application
9.2.5.3 Italy Vigabatrin Market
9.2.5.3.1 Italy Vigabatrin Market by Product
9.2.5.3.2 Italy Vigabatrin Market by Application
9.2.5.4 Spain Vigabatrin Market
9.2.5.4.1 Spain Vigabatrin Market by Product
9.2.5.4.2 Spain Vigabatrin Market by Application
9.2.5.5 United Kingdom Vigabatrin Market
9.2.5.5.1 United Kingdom Vigabatrin Market by Product
9.2.5.5.2 United Kingdom Vigabatrin Market by Application
9.2.5.6 Rest of Europe Vigabatrin Market
9.2.5.6.1 Rest of Europe Vigabatrin Market by Product
9.2.5.6.2 Rest of Europe Vigabatrin Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Vigabatrin Market Overview
9.3.2 Asia-Pacific Vigabatrin Market Forecasts and Analysis
9.3.3 Asia-Pacific Vigabatrin Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Vigabatrin Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Vigabatrin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Vigabatrin Market
9.3.5.1.1 Australia Vigabatrin Market by Product
9.3.5.1.2 Australia Vigabatrin Market by Application
9.3.5.2 China Vigabatrin Market
9.3.5.2.1 China Vigabatrin Market by Product
9.3.5.2.2 China Vigabatrin Market by Application
9.3.5.3 India Vigabatrin Market
9.3.5.3.1 India Vigabatrin Market by Product
9.3.5.3.2 India Vigabatrin Market by Application
9.3.5.4 Japan Vigabatrin Market
9.3.5.4.1 Japan Vigabatrin Market by Product
9.3.5.4.2 Japan Vigabatrin Market by Application
9.3.5.5 South Korea Vigabatrin Market
9.3.5.5.1 South Korea Vigabatrin Market by Product
9.3.5.5.2 South Korea Vigabatrin Market by Application
9.3.5.6 Rest of Asia-Pacific Vigabatrin Market
9.3.5.6.1 Rest of Asia-Pacific Vigabatrin Market by Product
9.3.5.6.2 Rest of Asia-Pacific Vigabatrin Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Vigabatrin Market Overview
9.4.2 Middle East and Africa Vigabatrin Market Forecasts and Analysis
9.4.3 Middle East and Africa Vigabatrin Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Vigabatrin Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Vigabatrin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Vigabatrin Market
9.4.5.1.1 South Africa Vigabatrin Market by Product
9.4.5.1.2 South Africa Vigabatrin Market by Application
9.4.5.2 Saudi Arabia Vigabatrin Market
9.4.5.2.1 Saudi Arabia Vigabatrin Market by Product
9.4.5.2.2 Saudi Arabia Vigabatrin Market by Application
9.4.5.3 U.A.E Vigabatrin Market
9.4.5.3.1 U.A.E Vigabatrin Market by Product
9.4.5.3.2 U.A.E Vigabatrin Market by Application
9.4.5.4 Rest of Middle East and Africa Vigabatrin Market
9.4.5.4.1 Rest of Middle East and Africa Vigabatrin Market by Product
9.4.5.4.2 Rest of Middle East and Africa Vigabatrin Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Vigabatrin Market Overview
9.5.2 South and Central America Vigabatrin Market Forecasts and Analysis
9.5.3 South and Central America Vigabatrin Market Forecasts and Analysis - By Product
9.5.4 South and Central America Vigabatrin Market Forecasts and Analysis - By Application
9.5.5 South and Central America Vigabatrin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Vigabatrin Market
9.5.5.1.1 Brazil Vigabatrin Market by Product
9.5.5.1.2 Brazil Vigabatrin Market by Application
9.5.5.2 Argentina Vigabatrin Market
9.5.5.2.1 Argentina Vigabatrin Market by Product
9.5.5.2.2 Argentina Vigabatrin Market by Application
9.5.5.3 Chile Vigabatrin Market
9.5.5.3.1 Chile Vigabatrin Market by Product
9.5.5.3.2 Chile Vigabatrin Market by Application
9.5.5.4 Rest of South and Central America Vigabatrin Market
9.5.5.4.1 Rest of South and Central America Vigabatrin Market by Product
9.5.5.4.2 Rest of South and Central America Vigabatrin Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. VIGABATRIN MARKET, KEY COMPANY PROFILES
11.1. AVENTIS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PAR PHARMACEUTICALS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. DR. REDDYS LABORATORIES
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ACCORD HEALTHCARE
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NAVISCI
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CIPLA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. AMNEAL
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. LUNDBECK
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. CAMBER
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. UPSHER-SMITH LABORATORIES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. DIVIS LABORATORIES
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Products and Services
11.11.4. Financial Overview
11.11.5. SWOT Analysis
11.11.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1.Aventis
2.Par Pharmaceuticals
3.Dr. Reddys Laboratories
4.Accord Healthcare
5.Navisci
6.Cipla
7.Amneal
8.Lundbeck
9.Camber
10.Upsher-Smith Laboratories
11.Divis Laboratories
TIPRE00025968
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.